H.R.759 - Food and Drug Administration Globalization Act of 2009 Sponsor: John Dingell / 111th Congress

Title
111th Congress - To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes. hidemore...
Summary
To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes. (by CRS)
Status
The bill has been introduced.

Customize

Customize the interests supporting and opposing this bill

To remove an interest, click the Remove button next to its name below this box.

To add an interest, choose one from this list:

To add an interest, click Support or Oppose.

You can share your customized pages with other people by sending them the URL for pages about this bill. Other MAPLight.org users will not see your customizations unless they use the URL you send them. To save your customizations for your next visit, create a free New Account, then Sign In.

Done

Interests who did want this bill to become law included these interests and specific groups:

Interests who did not want this bill to become law included these interests and specific groups:

Contribution data provided by the Center for Responsive Politics (OpenSecrets.org)

Comments RSS feed

Safety of imported drugs by Karen Chung, Mar 13, 2009 (6:46pm)

The FDA Globalization Act would create a registry of all food, drug, and device facilities serving Americans, require inspection of all facilities every two years, increase fees for these facilities to fund inspections, and empower the FDA to destroy counterfeit products. Opponents of this bill are afraid of that the imposition of fees would lead to the increase of prices of drugs and medical devices, affecting American consumers. Patients who cannot afford these new prices may have to resort to unregulated online pharmacies or give up medicine altogether.

Independent soap and cosmetics businesses are fighting to change certain provisions in the bill that unnecessarily affects them. The FDA Globalization Act would require all cosmetics establishments to submit a statement of ingredients for every cosmetic product. However, independent cosmetics businesses argue that small cosmetics producers produce large varieties of products in small batches, cater to one-time custom orders, and experiment by substituting minor ingredients in their products. According to these businesses, to submit an ingredients list for every single product would be overwhelming and unnecessary—especially because the ingredients they use are already regarded as safe.